Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001576280-25-000246
Filing Date
2025-07-30
Accepted
2025-07-30 17:13:33
Documents
85
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gh-20250630.htm   iXBRL 10-Q 1575370
2 EX-31.1 gh-6302025x10qxex311.htm EX-31.1 10192
3 EX-31.2 gh-6302025x10qxex312.htm EX-31.2 10184
4 EX-31.3 gh-6302025x10qxex313.htm EX-31.3 10288
5 EX-32.1 gh-6302025x10qxex321.htm EX-32.1 5846
6 EX-32.2 gh-6302025x10qxex322.htm EX-32.2 5848
7 EX-32.3 gh-6302025x10qxex323.htm EX-32.3 5889
  Complete submission text file 0001576280-25-000246.txt   9101957

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20250630.xsd EX-101.SCH 52274
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gh-20250630_cal.xml EX-101.CAL 88362
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gh-20250630_def.xml EX-101.DEF 318602
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20250630_lab.xml EX-101.LAB 739806
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20250630_pre.xml EX-101.PRE 530752
88 EXTRACTED XBRL INSTANCE DOCUMENT gh-20250630_htm.xml XML 1495050
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38683 | Film No.: 251168125
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)